Clinical research jobs provider Bristol-Myers Squibb (BMS) has announced the award of three new grants to improve prevention, diagnosis and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India.
It comes as part of the Delivering Hope:Awareness, Prevention and Care umbrella programme by the firm, which is committed to reducing hepatitis-related health disparities in Asia.
John Damonti, president of the Bristol-Myers Squibb Foundation, stated the scheme will have benefits such as being able to empower people in local communities with improved knowledge about prevention, diagnosis and care of HBV and HBC.
He said: "The Bristol-Myers Squibb Foundation continues to harness expertise and resources in community-based programmes and leverage those best practices to help others."
The history of BMS dates back for 125 years to when John Ripley Myers and William McLaren Bristol invested in a pharmaceuticals company in New York City.